tradingkey.logo
tradingkey.logo
검색

Metagenomi Inc

MGX
관심 목록에 추가
1.260USD
+0.050+4.13%
종가 07/02, 13:00ET시세는 15분 지연됩니다
47.44M시가총액
손실P/E TTM

자세한 내용은 Metagenomi Inc 회사

Metagenomi, Inc. is a precision genetic medicine company. The Company is focused on developing curative therapeutics for patients using its comprehensive metagenomics derived toolbox. Its diverse and modular genome editing toolbox is designed to precisely target any site in the human genome. Its comprehensive genome editing toolbox includes programmable nucleases, base editors, and RNA and DNA-mediated integration systems, including prime editing systems and clustered regularly interspaced short palindromic repeat (CRISPR)-associated transposases (CASTs). It has also developed a modular toolbox of genome editing systems that will allow it to interact with the human genome in a site-specific manner, where each tool can be matched to specific disease targets. The Company uses artificial intelligence and its metagenomics platform to develop curative genetic medicines.

Metagenomi Inc 정보

종목 코드 MGX
회사 이름Metagenomi Inc
상장일Feb 09, 2024
CEOIrish (Jian)
직원 수202
유형Ordinary Share
회계 연도 종료Feb 09
주소5959 Horton St
도시EMERYVILLE
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호94608
전화15108714880
웹사이트https://metagenomi.co/
종목 코드 MGX
상장일Feb 09, 2024
CEOIrish (Jian)

Metagenomi Inc의 회사 임원진

이름
이름/직위
직위
주식 보유
변동
Dr. Brian C. Thomas, Ph.D.
Dr. Brian C. Thomas, Ph.D.
Co-Founder, Director
Co-Founder, Director
2.40M
+1.61%
Dr. Jian Irish, Ph.D.
Dr. Jian Irish, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
600.86K
-0.62%
Dr. Sarah B. Noonberg, M.D., Ph.D.
Dr. Sarah B. Noonberg, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
109.14K
-4.80%
Dr. Juergen Eckhardt, M.D.
Dr. Juergen Eckhardt, M.D.
Independent Director
Independent Director
--
--
Dr. Willard H. Dere, M.D.
Dr. Willard H. Dere, M.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Pamela M. (Pam) Wapnick
Ms. Pamela M. (Pam) Wapnick
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Eric H. Bjerkholt
Mr. Eric H. Bjerkholt
Independent Director
Independent Director
--
--
,
,
Senior Vice President, Head of Legal, Compliance Officer and Corporate Secretary
Senior Vice President, Head of Legal, Compliance Officer and Corporate Secretary
--
--
Mr. Laurence E. Reid, Ph.D.
Mr. Laurence E. Reid, Ph.D.
Director
Director
--
--
이름
이름/직위
직위
주식 보유
변동
Dr. Brian C. Thomas, Ph.D.
Dr. Brian C. Thomas, Ph.D.
Co-Founder, Director
Co-Founder, Director
2.40M
+1.61%
Dr. Jian Irish, Ph.D.
Dr. Jian Irish, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
600.86K
-0.62%
Dr. Sarah B. Noonberg, M.D., Ph.D.
Dr. Sarah B. Noonberg, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
109.14K
-4.80%
Dr. Juergen Eckhardt, M.D.
Dr. Juergen Eckhardt, M.D.
Independent Director
Independent Director
--
--
Dr. Willard H. Dere, M.D.
Dr. Willard H. Dere, M.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Pamela M. (Pam) Wapnick
Ms. Pamela M. (Pam) Wapnick
Chief Financial Officer
Chief Financial Officer
--
--

자주 묻는 질문

Metagenomi Inc의 상위 5대 주주는 누구인가요?

Metagenomi Inc의 상위 5대 주주는 다음과 같습니다: Dr. Brian C. Thomas, Ph.D.

Metagenomi Inc(MGX)의 주식을 보유한 기관은 몇 개입니까?

2026Q1 기준으로, Metagenomi Inc의 주식을 보유한 기관은 총 172곳이며, 이들이 보유한 주식의 총 가치는 약 8.82M로 전체 발행 주식의 23.43%를 차지합니다. 이는 2025Q4 대비 -6411264.00 증가한 수치입니다.